nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—SLC15A2—multiple sclerosis	0.459	0.823	CbGaD
Nateglinide—ALB—multiple sclerosis	0.0988	0.177	CbGaD
Nateglinide—SLC16A1—Methotrexate—multiple sclerosis	0.0639	0.212	CbGbCtD
Nateglinide—ABCC4—Methotrexate—multiple sclerosis	0.0307	0.102	CbGbCtD
Nateglinide—CYP2D6—Fingolimod—multiple sclerosis	0.0286	0.0951	CbGbCtD
Nateglinide—ALB—Prednisone—multiple sclerosis	0.0227	0.0753	CbGbCtD
Nateglinide—CYP3A4—Fingolimod—multiple sclerosis	0.0182	0.0605	CbGbCtD
Nateglinide—CYP3A7—Dexamethasone—multiple sclerosis	0.0152	0.0504	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0152	0.0504	CbGbCtD
Nateglinide—SLC22A6—Methotrexate—multiple sclerosis	0.0134	0.0444	CbGbCtD
Nateglinide—CYP3A4—Methylprednisolone—multiple sclerosis	0.0117	0.039	CbGbCtD
Nateglinide—CYP3A5—Dexamethasone—multiple sclerosis	0.0114	0.0378	CbGbCtD
Nateglinide—ALB—Methotrexate—multiple sclerosis	0.0114	0.0378	CbGbCtD
Nateglinide—CYP3A4—Triamcinolone—multiple sclerosis	0.00889	0.0295	CbGbCtD
Nateglinide—CYP3A4—Mitoxantrone—multiple sclerosis	0.00856	0.0284	CbGbCtD
Nateglinide—CYP2C9—Dexamethasone—multiple sclerosis	0.00763	0.0253	CbGbCtD
Nateglinide—CYP3A4—Betamethasone—multiple sclerosis	0.00763	0.0253	CbGbCtD
Nateglinide—CYP3A4—Prednisolone—multiple sclerosis	0.00753	0.025	CbGbCtD
Nateglinide—CYP3A4—Prednisone—multiple sclerosis	0.00711	0.0236	CbGbCtD
Nateglinide—CYP2D6—Dexamethasone—multiple sclerosis	0.00698	0.0232	CbGbCtD
Nateglinide—CYP3A4—Dexamethasone—multiple sclerosis	0.00444	0.0147	CbGbCtD
Nateglinide—Hepatic enzyme increased—Fingolimod—multiple sclerosis	0.00214	0.031	CcSEcCtD
Nateglinide—PPARG—leg—multiple sclerosis	0.00203	0.137	CbGeAlD
Nateglinide—Trauma—Prednisolone—multiple sclerosis	0.0013	0.0188	CcSEcCtD
Nateglinide—Influenza—Fingolimod—multiple sclerosis	0.00127	0.0184	CcSEcCtD
Nateglinide—Bronchitis—Fingolimod—multiple sclerosis	0.00122	0.0177	CcSEcCtD
Nateglinide—Trauma—Triamcinolone—multiple sclerosis	0.0012	0.0173	CcSEcCtD
Nateglinide—Trauma—Methylprednisolone—multiple sclerosis	0.00119	0.0173	CcSEcCtD
Nateglinide—Spirapril—SLC15A2—multiple sclerosis	0.00112	0.246	CrCbGaD
Nateglinide—Trauma—Dexamethasone—multiple sclerosis	0.00109	0.0157	CcSEcCtD
Nateglinide—Trauma—Betamethasone—multiple sclerosis	0.00109	0.0157	CcSEcCtD
Nateglinide—Cilazapril—SLC15A2—multiple sclerosis	0.000999	0.219	CrCbGaD
Nateglinide—Trandolapril—SLC15A2—multiple sclerosis	0.000967	0.212	CrCbGaD
Nateglinide—Ramipril—SLC15A2—multiple sclerosis	0.000967	0.212	CrCbGaD
Nateglinide—Trauma—Prednisone—multiple sclerosis	0.000945	0.0137	CcSEcCtD
Nateglinide—Back pain—Fingolimod—multiple sclerosis	0.000857	0.0124	CcSEcCtD
Nateglinide—Hepatic enzyme increased—Mitoxantrone—multiple sclerosis	0.000798	0.0116	CcSEcCtD
Nateglinide—Palpitations—Fingolimod—multiple sclerosis	0.000783	0.0113	CcSEcCtD
Nateglinide—Cough—Fingolimod—multiple sclerosis	0.000773	0.0112	CcSEcCtD
Nateglinide—Sweating increased—Cladribine—multiple sclerosis	0.000702	0.0102	CcSEcCtD
Nateglinide—Arthropathy—Prednisolone—multiple sclerosis	0.000681	0.00987	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Cladribine—multiple sclerosis	0.00067	0.0097	CcSEcCtD
Nateglinide—Arthropathy—Triamcinolone—multiple sclerosis	0.000626	0.00907	CcSEcCtD
Nateglinide—Arthropathy—Methylprednisolone—multiple sclerosis	0.000625	0.00905	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.000624	0.00904	CcSEcCtD
Nateglinide—Fatigue—Fingolimod—multiple sclerosis	0.000623	0.00903	CcSEcCtD
Nateglinide—ABCC8—brainstem—multiple sclerosis	0.00062	0.0419	CbGeAlD
Nateglinide—Hepatobiliary disease—Cladribine—multiple sclerosis	0.000608	0.0088	CcSEcCtD
Nateglinide—Arthropathy—Betamethasone—multiple sclerosis	0.000568	0.00823	CcSEcCtD
Nateglinide—Arthropathy—Dexamethasone—multiple sclerosis	0.000568	0.00823	CcSEcCtD
Nateglinide—Oedema peripheral—Cladribine—multiple sclerosis	0.000568	0.00823	CcSEcCtD
Nateglinide—Erythema multiforme—Cladribine—multiple sclerosis	0.000545	0.0079	CcSEcCtD
Nateglinide—SLC16A1—retina—multiple sclerosis	0.000544	0.0368	CbGeAlD
Nateglinide—Immune system disorder—Cladribine—multiple sclerosis	0.000521	0.00755	CcSEcCtD
Nateglinide—Asthenia—Fingolimod—multiple sclerosis	0.000519	0.00751	CcSEcCtD
Nateglinide—Pruritus—Fingolimod—multiple sclerosis	0.000511	0.00741	CcSEcCtD
Nateglinide—Ramipril—BCHE—multiple sclerosis	0.000507	0.111	CrCbGaD
Nateglinide—Malnutrition—Cladribine—multiple sclerosis	0.000502	0.00727	CcSEcCtD
Nateglinide—Arthropathy—Prednisone—multiple sclerosis	0.000495	0.00717	CcSEcCtD
Nateglinide—Diarrhoea—Fingolimod—multiple sclerosis	0.000495	0.00716	CcSEcCtD
Nateglinide—Hepatobiliary disease—Azathioprine—multiple sclerosis	0.000494	0.00716	CcSEcCtD
Nateglinide—Injury—Prednisolone—multiple sclerosis	0.000489	0.00709	CcSEcCtD
Nateglinide—Back pain—Cladribine—multiple sclerosis	0.000486	0.00704	CcSEcCtD
Nateglinide—Increased appetite—Prednisolone—multiple sclerosis	0.000478	0.00693	CcSEcCtD
Nateglinide—Dizziness—Fingolimod—multiple sclerosis	0.000478	0.00692	CcSEcCtD
Nateglinide—Sweating increased—Mitoxantrone—multiple sclerosis	0.000461	0.00668	CcSEcCtD
Nateglinide—Injury—Triamcinolone—multiple sclerosis	0.00045	0.00652	CcSEcCtD
Nateglinide—Osteoarthritis—Prednisolone—multiple sclerosis	0.00045	0.00651	CcSEcCtD
Nateglinide—Injury—Methylprednisolone—multiple sclerosis	0.000449	0.0065	CcSEcCtD
Nateglinide—Erythema multiforme—Azathioprine—multiple sclerosis	0.000443	0.00642	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Mitoxantrone—multiple sclerosis	0.00044	0.00638	CcSEcCtD
Nateglinide—Increased appetite—Triamcinolone—multiple sclerosis	0.00044	0.00637	CcSEcCtD
Nateglinide—Increased appetite—Methylprednisolone—multiple sclerosis	0.000439	0.00636	CcSEcCtD
Nateglinide—Cough—Cladribine—multiple sclerosis	0.000438	0.00635	CcSEcCtD
Nateglinide—ABCC8—medulla oblongata—multiple sclerosis	0.000432	0.0292	CbGeAlD
Nateglinide—Immune system disorder—Azathioprine—multiple sclerosis	0.000424	0.00614	CcSEcCtD
Nateglinide—Osteoarthritis—Triamcinolone—multiple sclerosis	0.000413	0.00599	CcSEcCtD
Nateglinide—Osteoarthritis—Methylprednisolone—multiple sclerosis	0.000412	0.00598	CcSEcCtD
Nateglinide—Jaundice—Mitoxantrone—multiple sclerosis	0.000412	0.00596	CcSEcCtD
Nateglinide—Injury—Betamethasone—multiple sclerosis	0.000408	0.00591	CcSEcCtD
Nateglinide—Injury—Dexamethasone—multiple sclerosis	0.000408	0.00591	CcSEcCtD
Nateglinide—Sweating—Mitoxantrone—multiple sclerosis	0.000405	0.00587	CcSEcCtD
Nateglinide—Increased appetite—Dexamethasone—multiple sclerosis	0.000399	0.00578	CcSEcCtD
Nateglinide—Increased appetite—Betamethasone—multiple sclerosis	0.000399	0.00578	CcSEcCtD
Nateglinide—Hepatic enzyme increased—Methotrexate—multiple sclerosis	0.000398	0.00576	CcSEcCtD
Nateglinide—Hyperhidrosis—Cladribine—multiple sclerosis	0.000396	0.00574	CcSEcCtD
Nateglinide—ABCC8—midbrain—multiple sclerosis	0.000395	0.0267	CbGeAlD
Nateglinide—SLC16A1—medulla oblongata—multiple sclerosis	0.000393	0.0266	CbGeAlD
Nateglinide—ABCC8—spinal cord—multiple sclerosis	0.000385	0.026	CbGeAlD
Nateglinide—Sweating increased—Prednisolone—multiple sclerosis	0.000378	0.00548	CcSEcCtD
Nateglinide—Osteoarthritis—Betamethasone—multiple sclerosis	0.000375	0.00543	CcSEcCtD
Nateglinide—Osteoarthritis—Dexamethasone—multiple sclerosis	0.000375	0.00543	CcSEcCtD
Nateglinide—SLC16A1—midbrain—multiple sclerosis	0.000359	0.0243	CbGeAlD
Nateglinide—Influenza—Triamcinolone—multiple sclerosis	0.000357	0.00518	CcSEcCtD
Nateglinide—SLC15A2—retina—multiple sclerosis	0.000357	0.0241	CbGeAlD
Nateglinide—Injury—Prednisone—multiple sclerosis	0.000355	0.00515	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000354	0.00512	CcSEcCtD
Nateglinide—Fatigue—Cladribine—multiple sclerosis	0.000353	0.00512	CcSEcCtD
Nateglinide—KCNJ11—nervous system—multiple sclerosis	0.000352	0.0238	CbGeAlD
Nateglinide—SLC16A1—spinal cord—multiple sclerosis	0.000351	0.0237	CbGeAlD
Nateglinide—Sweating increased—Triamcinolone—multiple sclerosis	0.000348	0.00504	CcSEcCtD
Nateglinide—Increased appetite—Prednisone—multiple sclerosis	0.000348	0.00504	CcSEcCtD
Nateglinide—Sweating increased—Methylprednisolone—multiple sclerosis	0.000347	0.00503	CcSEcCtD
Nateglinide—Bronchitis—Triamcinolone—multiple sclerosis	0.000344	0.00498	CcSEcCtD
Nateglinide—Urine output increased—Methotrexate—multiple sclerosis	0.00034	0.00493	CcSEcCtD
Nateglinide—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.00034	0.00492	CcSEcCtD
Nateglinide—KCNJ11—central nervous system—multiple sclerosis	0.000339	0.0229	CbGeAlD
Nateglinide—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000335	0.00485	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.000332	0.00481	CcSEcCtD
Nateglinide—KCNJ11—cerebellum—multiple sclerosis	0.000332	0.0224	CbGeAlD
Nateglinide—Osteoarthritis—Prednisone—multiple sclerosis	0.000327	0.00473	CcSEcCtD
Nateglinide—Urticaria—Cladribine—multiple sclerosis	0.000325	0.00472	CcSEcCtD
Nateglinide—ABCC8—nervous system—multiple sclerosis	0.000325	0.0219	CbGeAlD
Nateglinide—Abdominal pain—Cladribine—multiple sclerosis	0.000324	0.00469	CcSEcCtD
Nateglinide—Back pain—Mitoxantrone—multiple sclerosis	0.000319	0.00462	CcSEcCtD
Nateglinide—Sweating increased—Dexamethasone—multiple sclerosis	0.000316	0.00458	CcSEcCtD
Nateglinide—Sweating increased—Betamethasone—multiple sclerosis	0.000316	0.00458	CcSEcCtD
Nateglinide—ORM1—spinal cord—multiple sclerosis	0.000315	0.0213	CbGeAlD
Nateglinide—ABCC8—central nervous system—multiple sclerosis	0.000313	0.0211	CbGeAlD
Nateglinide—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.000312	0.00452	CcSEcCtD
Nateglinide—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.000312	0.00451	CcSEcCtD
Nateglinide—Polyuria—Methotrexate—multiple sclerosis	0.000311	0.0045	CcSEcCtD
Nateglinide—ABCC8—cerebellum—multiple sclerosis	0.000306	0.0206	CbGeAlD
Nateglinide—Sweating—Methylprednisolone—multiple sclerosis	0.000305	0.00442	CcSEcCtD
Nateglinide—Hypersensitivity—Cladribine—multiple sclerosis	0.000302	0.00437	CcSEcCtD
Nateglinide—SLC16A1—nervous system—multiple sclerosis	0.000295	0.02	CbGeAlD
Nateglinide—Asthenia—Cladribine—multiple sclerosis	0.000294	0.00426	CcSEcCtD
Nateglinide—Pruritus—Cladribine—multiple sclerosis	0.00029	0.0042	CcSEcCtD
Nateglinide—Cough—Mitoxantrone—multiple sclerosis	0.000288	0.00417	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000288	0.00417	CcSEcCtD
Nateglinide—SLC22A6—brain—multiple sclerosis	0.000285	0.0193	CbGeAlD
Nateglinide—SLC16A1—central nervous system—multiple sclerosis	0.000284	0.0192	CbGeAlD
Nateglinide—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000283	0.00411	CcSEcCtD
Nateglinide—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000283	0.00411	CcSEcCtD
Nateglinide—Diarrhoea—Cladribine—multiple sclerosis	0.00028	0.00406	CcSEcCtD
Nateglinide—SLC16A1—cerebellum—multiple sclerosis	0.000278	0.0188	CbGeAlD
Nateglinide—Sweating increased—Prednisone—multiple sclerosis	0.000275	0.00398	CcSEcCtD
Nateglinide—Osteoarthritis—Methotrexate—multiple sclerosis	0.000273	0.00396	CcSEcCtD
Nateglinide—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000272	0.00395	CcSEcCtD
Nateglinide—Dizziness—Cladribine—multiple sclerosis	0.000271	0.00393	CcSEcCtD
Nateglinide—KCNJ11—brain—multiple sclerosis	0.000269	0.0182	CbGeAlD
Nateglinide—ORM1—nervous system—multiple sclerosis	0.000265	0.0179	CbGeAlD
Nateglinide—Abdominal pain—Azathioprine—multiple sclerosis	0.000263	0.00382	CcSEcCtD
Nateglinide—Vomiting—Cladribine—multiple sclerosis	0.00026	0.00377	CcSEcCtD
Nateglinide—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00026	0.00377	CcSEcCtD
Nateglinide—Rash—Cladribine—multiple sclerosis	0.000258	0.00374	CcSEcCtD
Nateglinide—SLC15A2—medulla oblongata—multiple sclerosis	0.000258	0.0175	CbGeAlD
Nateglinide—Dermatitis—Cladribine—multiple sclerosis	0.000258	0.00374	CcSEcCtD
Nateglinide—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000258	0.00373	CcSEcCtD
Nateglinide—ORM1—central nervous system—multiple sclerosis	0.000255	0.0172	CbGeAlD
Nateglinide—Malnutrition—Methylprednisolone—multiple sclerosis	0.000248	0.0036	CcSEcCtD
Nateglinide—ABCC8—brain—multiple sclerosis	0.000248	0.0168	CbGeAlD
Nateglinide—PPARG—nervous system—multiple sclerosis	0.000248	0.0167	CbGeAlD
Nateglinide—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000247	0.00358	CcSEcCtD
Nateglinide—Hypersensitivity—Azathioprine—multiple sclerosis	0.000245	0.00356	CcSEcCtD
Nateglinide—Nausea—Cladribine—multiple sclerosis	0.000243	0.00353	CcSEcCtD
Nateglinide—Back pain—Triamcinolone—multiple sclerosis	0.000241	0.00349	CcSEcCtD
Nateglinide—PPARG—central nervous system—multiple sclerosis	0.000239	0.0161	CbGeAlD
Nateglinide—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000237	0.00343	CcSEcCtD
Nateglinide—SLC15A2—midbrain—multiple sclerosis	0.000236	0.016	CbGeAlD
Nateglinide—Fatigue—Mitoxantrone—multiple sclerosis	0.000232	0.00336	CcSEcCtD
Nateglinide—SLC15A2—spinal cord—multiple sclerosis	0.00023	0.0156	CbGeAlD
Nateglinide—Diarrhoea—Azathioprine—multiple sclerosis	0.000228	0.0033	CcSEcCtD
Nateglinide—SLC16A1—brain—multiple sclerosis	0.000226	0.0153	CbGeAlD
Nateglinide—ABCC4—nervous system—multiple sclerosis	0.000225	0.0152	CbGeAlD
Nateglinide—Dizziness—Azathioprine—multiple sclerosis	0.00022	0.00319	CcSEcCtD
Nateglinide—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00022	0.00319	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000219	0.00318	CcSEcCtD
Nateglinide—Cough—Triamcinolone—multiple sclerosis	0.000217	0.00315	CcSEcCtD
Nateglinide—ABCC4—central nervous system—multiple sclerosis	0.000217	0.0146	CbGeAlD
Nateglinide—Urticaria—Mitoxantrone—multiple sclerosis	0.000214	0.0031	CcSEcCtD
Nateglinide—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000214	0.00309	CcSEcCtD
Nateglinide—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000213	0.00308	CcSEcCtD
Nateglinide—Vomiting—Azathioprine—multiple sclerosis	0.000212	0.00307	CcSEcCtD
Nateglinide—Rash—Azathioprine—multiple sclerosis	0.00021	0.00304	CcSEcCtD
Nateglinide—Dermatitis—Azathioprine—multiple sclerosis	0.00021	0.00304	CcSEcCtD
Nateglinide—CYP2D6—brainstem—multiple sclerosis	0.000208	0.014	CbGeAlD
Nateglinide—Immune system disorder—Prednisone—multiple sclerosis	0.000204	0.00296	CcSEcCtD
Nateglinide—Sweating—Methotrexate—multiple sclerosis	0.000202	0.00292	CcSEcCtD
Nateglinide—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000199	0.00288	CcSEcCtD
Nateglinide—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000198	0.00287	CcSEcCtD
Nateglinide—Nausea—Azathioprine—multiple sclerosis	0.000198	0.00287	CcSEcCtD
Nateglinide—Malnutrition—Prednisone—multiple sclerosis	0.000197	0.00285	CcSEcCtD
Nateglinide—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000196	0.00285	CcSEcCtD
Nateglinide—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000196	0.00284	CcSEcCtD
Nateglinide—SLC15A2—nervous system—multiple sclerosis	0.000194	0.0131	CbGeAlD
Nateglinide—Asthenia—Mitoxantrone—multiple sclerosis	0.000193	0.0028	CcSEcCtD
Nateglinide—PPARG—brain—multiple sclerosis	0.000189	0.0128	CbGeAlD
Nateglinide—SLC15A2—central nervous system—multiple sclerosis	0.000187	0.0126	CbGeAlD
Nateglinide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000184	0.00267	CcSEcCtD
Nateglinide—SLC15A2—cerebellum—multiple sclerosis	0.000183	0.0123	CbGeAlD
Nateglinide—Dyspepsia—Triamcinolone—multiple sclerosis	0.000179	0.00259	CcSEcCtD
Nateglinide—Erythema multiforme—Methotrexate—multiple sclerosis	0.000179	0.00259	CcSEcCtD
Nateglinide—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000178	0.00259	CcSEcCtD
Nateglinide—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000178	0.00258	CcSEcCtD
Nateglinide—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000178	0.00258	CcSEcCtD
Nateglinide—ALB—brain—multiple sclerosis	0.000178	0.012	CbGeAlD
Nateglinide—Urticaria—Prednisolone—multiple sclerosis	0.000176	0.00254	CcSEcCtD
Nateglinide—Fatigue—Triamcinolone—multiple sclerosis	0.000175	0.00254	CcSEcCtD
Nateglinide—Fatigue—Methylprednisolone—multiple sclerosis	0.000175	0.00253	CcSEcCtD
Nateglinide—ABCC4—brain—multiple sclerosis	0.000172	0.0116	CbGeAlD
Nateglinide—Vomiting—Mitoxantrone—multiple sclerosis	0.000171	0.00248	CcSEcCtD
Nateglinide—Immune system disorder—Methotrexate—multiple sclerosis	0.000171	0.00247	CcSEcCtD
Nateglinide—Rash—Mitoxantrone—multiple sclerosis	0.00017	0.00246	CcSEcCtD
Nateglinide—Dermatitis—Mitoxantrone—multiple sclerosis	0.00017	0.00246	CcSEcCtD
Nateglinide—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000166	0.0024	CcSEcCtD
Nateglinide—Malnutrition—Methotrexate—multiple sclerosis	0.000164	0.00238	CcSEcCtD
Nateglinide—Hypersensitivity—Prednisolone—multiple sclerosis	0.000163	0.00236	CcSEcCtD
Nateglinide—Dyspepsia—Betamethasone—multiple sclerosis	0.000162	0.00235	CcSEcCtD
Nateglinide—Dyspepsia—Dexamethasone—multiple sclerosis	0.000162	0.00235	CcSEcCtD
Nateglinide—Urticaria—Triamcinolone—multiple sclerosis	0.000161	0.00234	CcSEcCtD
Nateglinide—Urticaria—Methylprednisolone—multiple sclerosis	0.000161	0.00233	CcSEcCtD
Nateglinide—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00016	0.00232	CcSEcCtD
Nateglinide—Nausea—Mitoxantrone—multiple sclerosis	0.00016	0.00232	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000159	0.00231	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000159	0.00231	CcSEcCtD
Nateglinide—Back pain—Methotrexate—multiple sclerosis	0.000159	0.0023	CcSEcCtD
Nateglinide—Fatigue—Dexamethasone—multiple sclerosis	0.000159	0.0023	CcSEcCtD
Nateglinide—Fatigue—Betamethasone—multiple sclerosis	0.000159	0.0023	CcSEcCtD
Nateglinide—PTGS1—spinal cord—multiple sclerosis	0.000157	0.0106	CbGeAlD
Nateglinide—Hyperhidrosis—Prednisone—multiple sclerosis	0.000155	0.00225	CcSEcCtD
Nateglinide—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000151	0.00218	CcSEcCtD
Nateglinide—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000151	0.00218	CcSEcCtD
Nateglinide—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00015	0.00217	CcSEcCtD
Nateglinide—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000149	0.00216	CcSEcCtD
Nateglinide—SLC15A2—brain—multiple sclerosis	0.000148	0.01	CbGeAlD
Nateglinide—Urticaria—Dexamethasone—multiple sclerosis	0.000146	0.00212	CcSEcCtD
Nateglinide—Urticaria—Betamethasone—multiple sclerosis	0.000146	0.00212	CcSEcCtD
Nateglinide—Dizziness—Prednisolone—multiple sclerosis	0.000146	0.00212	CcSEcCtD
Nateglinide—Asthenia—Triamcinolone—multiple sclerosis	0.000146	0.00211	CcSEcCtD
Nateglinide—Abdominal pain—Betamethasone—multiple sclerosis	0.000146	0.00211	CcSEcCtD
Nateglinide—Abdominal pain—Dexamethasone—multiple sclerosis	0.000146	0.00211	CcSEcCtD
Nateglinide—Asthenia—Methylprednisolone—multiple sclerosis	0.000145	0.00211	CcSEcCtD
Nateglinide—Pruritus—Triamcinolone—multiple sclerosis	0.000144	0.00208	CcSEcCtD
Nateglinide—Cough—Methotrexate—multiple sclerosis	0.000143	0.00208	CcSEcCtD
Nateglinide—Pruritus—Methylprednisolone—multiple sclerosis	0.000143	0.00208	CcSEcCtD
Nateglinide—Dyspepsia—Prednisone—multiple sclerosis	0.000141	0.00205	CcSEcCtD
Nateglinide—Rash—Prednisolone—multiple sclerosis	0.000139	0.00202	CcSEcCtD
Nateglinide—Dermatitis—Prednisolone—multiple sclerosis	0.000139	0.00202	CcSEcCtD
Nateglinide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000139	0.00201	CcSEcCtD
Nateglinide—Fatigue—Prednisone—multiple sclerosis	0.000138	0.00201	CcSEcCtD
Nateglinide—Dizziness—Triamcinolone—multiple sclerosis	0.000134	0.00195	CcSEcCtD
Nateglinide—Dizziness—Methylprednisolone—multiple sclerosis	0.000134	0.00194	CcSEcCtD
Nateglinide—PTGS1—nervous system—multiple sclerosis	0.000132	0.00895	CbGeAlD
Nateglinide—Asthenia—Betamethasone—multiple sclerosis	0.000132	0.00192	CcSEcCtD
Nateglinide—Asthenia—Dexamethasone—multiple sclerosis	0.000132	0.00192	CcSEcCtD
Nateglinide—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000131	0.0019	CcSEcCtD
Nateglinide—Nausea—Prednisolone—multiple sclerosis	0.000131	0.0019	CcSEcCtD
Nateglinide—Pruritus—Dexamethasone—multiple sclerosis	0.00013	0.00189	CcSEcCtD
Nateglinide—Pruritus—Betamethasone—multiple sclerosis	0.00013	0.00189	CcSEcCtD
Nateglinide—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00013	0.00188	CcSEcCtD
Nateglinide—Vomiting—Triamcinolone—multiple sclerosis	0.000129	0.00187	CcSEcCtD
Nateglinide—Vomiting—Methylprednisolone—multiple sclerosis	0.000129	0.00187	CcSEcCtD
Nateglinide—Rash—Triamcinolone—multiple sclerosis	0.000128	0.00186	CcSEcCtD
Nateglinide—Dermatitis—Triamcinolone—multiple sclerosis	0.000128	0.00185	CcSEcCtD
Nateglinide—Rash—Methylprednisolone—multiple sclerosis	0.000128	0.00185	CcSEcCtD
Nateglinide—Dermatitis—Methylprednisolone—multiple sclerosis	0.000128	0.00185	CcSEcCtD
Nateglinide—PTGS1—central nervous system—multiple sclerosis	0.000128	0.00862	CbGeAlD
Nateglinide—Urticaria—Prednisone—multiple sclerosis	0.000128	0.00185	CcSEcCtD
Nateglinide—Abdominal pain—Prednisone—multiple sclerosis	0.000127	0.00184	CcSEcCtD
Nateglinide—Diarrhoea—Betamethasone—multiple sclerosis	0.000126	0.00183	CcSEcCtD
Nateglinide—Diarrhoea—Dexamethasone—multiple sclerosis	0.000126	0.00183	CcSEcCtD
Nateglinide—Dizziness—Betamethasone—multiple sclerosis	0.000122	0.00177	CcSEcCtD
Nateglinide—Dizziness—Dexamethasone—multiple sclerosis	0.000122	0.00177	CcSEcCtD
Nateglinide—Nausea—Triamcinolone—multiple sclerosis	0.000121	0.00175	CcSEcCtD
Nateglinide—Nausea—Methylprednisolone—multiple sclerosis	0.00012	0.00174	CcSEcCtD
Nateglinide—Hypersensitivity—Prednisone—multiple sclerosis	0.000118	0.00171	CcSEcCtD
Nateglinide—Dyspepsia—Methotrexate—multiple sclerosis	0.000118	0.00171	CcSEcCtD
Nateglinide—Vomiting—Betamethasone—multiple sclerosis	0.000117	0.0017	CcSEcCtD
Nateglinide—Vomiting—Dexamethasone—multiple sclerosis	0.000117	0.0017	CcSEcCtD
Nateglinide—Rash—Betamethasone—multiple sclerosis	0.000116	0.00168	CcSEcCtD
Nateglinide—Rash—Dexamethasone—multiple sclerosis	0.000116	0.00168	CcSEcCtD
Nateglinide—Dermatitis—Dexamethasone—multiple sclerosis	0.000116	0.00168	CcSEcCtD
Nateglinide—Dermatitis—Betamethasone—multiple sclerosis	0.000116	0.00168	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000116	0.00168	CcSEcCtD
Nateglinide—Fatigue—Methotrexate—multiple sclerosis	0.000116	0.00168	CcSEcCtD
Nateglinide—Asthenia—Prednisone—multiple sclerosis	0.000115	0.00167	CcSEcCtD
Nateglinide—Pruritus—Prednisone—multiple sclerosis	0.000114	0.00165	CcSEcCtD
Nateglinide—CYP3A4—nervous system—multiple sclerosis	0.000111	0.00748	CbGeAlD
Nateglinide—Diarrhoea—Prednisone—multiple sclerosis	0.00011	0.00159	CcSEcCtD
Nateglinide—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00011	0.00159	CcSEcCtD
Nateglinide—Nausea—Betamethasone—multiple sclerosis	0.00011	0.00159	CcSEcCtD
Nateglinide—Nausea—Dexamethasone—multiple sclerosis	0.00011	0.00159	CcSEcCtD
Nateglinide—CYP2D6—nervous system—multiple sclerosis	0.000109	0.00736	CbGeAlD
Nateglinide—Urticaria—Methotrexate—multiple sclerosis	0.000107	0.00154	CcSEcCtD
Nateglinide—CYP3A4—central nervous system—multiple sclerosis	0.000107	0.0072	CbGeAlD
Nateglinide—Dizziness—Prednisone—multiple sclerosis	0.000106	0.00154	CcSEcCtD
Nateglinide—Abdominal pain—Methotrexate—multiple sclerosis	0.000106	0.00154	CcSEcCtD
Nateglinide—CYP2D6—central nervous system—multiple sclerosis	0.000105	0.00709	CbGeAlD
Nateglinide—CYP2D6—cerebellum—multiple sclerosis	0.000102	0.00693	CbGeAlD
Nateglinide—Vomiting—Prednisone—multiple sclerosis	0.000102	0.00148	CcSEcCtD
Nateglinide—PTGS1—brain—multiple sclerosis	0.000101	0.00684	CbGeAlD
Nateglinide—Rash—Prednisone—multiple sclerosis	0.000101	0.00147	CcSEcCtD
Nateglinide—Dermatitis—Prednisone—multiple sclerosis	0.000101	0.00147	CcSEcCtD
Nateglinide—Hypersensitivity—Methotrexate—multiple sclerosis	9.89e-05	0.00143	CcSEcCtD
Nateglinide—Asthenia—Methotrexate—multiple sclerosis	9.63e-05	0.00139	CcSEcCtD
Nateglinide—Nausea—Prednisone—multiple sclerosis	9.54e-05	0.00138	CcSEcCtD
Nateglinide—Pruritus—Methotrexate—multiple sclerosis	9.49e-05	0.00138	CcSEcCtD
Nateglinide—Diarrhoea—Methotrexate—multiple sclerosis	9.18e-05	0.00133	CcSEcCtD
Nateglinide—Dizziness—Methotrexate—multiple sclerosis	8.87e-05	0.00129	CcSEcCtD
Nateglinide—Vomiting—Methotrexate—multiple sclerosis	8.53e-05	0.00124	CcSEcCtD
Nateglinide—Rash—Methotrexate—multiple sclerosis	8.46e-05	0.00123	CcSEcCtD
Nateglinide—Dermatitis—Methotrexate—multiple sclerosis	8.45e-05	0.00122	CcSEcCtD
Nateglinide—CYP2D6—brain—multiple sclerosis	8.32e-05	0.00563	CbGeAlD
Nateglinide—Nausea—Methotrexate—multiple sclerosis	7.97e-05	0.00115	CcSEcCtD
Nateglinide—PPARG—Metabolism—SRM—multiple sclerosis	5.54e-05	0.00105	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.53e-05	0.00105	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—SELE—multiple sclerosis	5.5e-05	0.00105	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	5.47e-05	0.00104	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	5.47e-05	0.00104	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CYP27B1—multiple sclerosis	5.44e-05	0.00104	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CYP24A1—multiple sclerosis	5.44e-05	0.00104	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—ICAM1—multiple sclerosis	5.43e-05	0.00103	CbGpPWpGaD
Nateglinide—ABCC4—Platelet degranulation—TGFB1—multiple sclerosis	5.43e-05	0.00103	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—HNRNPA1—multiple sclerosis	5.4e-05	0.00103	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—U2AF2—multiple sclerosis	5.4e-05	0.00103	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.34e-05	0.00102	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—ITGA4—multiple sclerosis	5.33e-05	0.00101	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—IFNB1—multiple sclerosis	5.29e-05	0.00101	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CYP24A1—multiple sclerosis	5.28e-05	0.00101	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CYP27B1—multiple sclerosis	5.28e-05	0.00101	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	5.27e-05	0.001	CbGpPWpGaD
Nateglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—multiple sclerosis	5.26e-05	0.001	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CYP27B1—multiple sclerosis	5.2e-05	0.000991	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CYP24A1—multiple sclerosis	5.2e-05	0.000991	CbGpPWpGaD
Nateglinide—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	5.17e-05	0.000985	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	5.11e-05	0.000973	CbGpPWpGaD
Nateglinide—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	5.08e-05	0.000967	CbGpPWpGaD
Nateglinide—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.05e-05	0.000961	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GPC5—multiple sclerosis	4.98e-05	0.000948	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—PGR—multiple sclerosis	4.88e-05	0.000929	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—CCL2—multiple sclerosis	4.86e-05	0.000926	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—GPC5—multiple sclerosis	4.83e-05	0.000919	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—SRM—multiple sclerosis	4.76e-05	0.000906	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GPC5—multiple sclerosis	4.76e-05	0.000906	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.72e-05	0.000898	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.65e-05	0.000885	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	4.56e-05	0.000868	CbGpPWpGaD
Nateglinide—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	4.53e-05	0.000863	CbGpPWpGaD
Nateglinide—SLC16A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.48e-05	0.000854	CbGpPWpGaD
Nateglinide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.43e-05	0.000843	CbGpPWpGaD
Nateglinide—UGT1A9—Biological oxidations—POMC—multiple sclerosis	4.41e-05	0.00084	CbGpPWpGaD
Nateglinide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.39e-05	0.000836	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—PTPRC—multiple sclerosis	4.38e-05	0.000834	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	4.32e-05	0.000822	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—ZFP36L1—multiple sclerosis	4.27e-05	0.000812	CbGpPWpGaD
Nateglinide—SLC15A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.22e-05	0.000804	CbGpPWpGaD
Nateglinide—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	4.2e-05	0.0008	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—IFNG—multiple sclerosis	4.13e-05	0.000787	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—RRM1—multiple sclerosis	4.13e-05	0.000786	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.11e-05	0.000782	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.03e-05	0.000768	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—SRM—multiple sclerosis	4e-05	0.000762	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—RRM1—multiple sclerosis	4e-05	0.000762	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—STAT3—multiple sclerosis	3.99e-05	0.00076	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—ITGA4—multiple sclerosis	3.97e-05	0.000756	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—IFNB1—multiple sclerosis	3.94e-05	0.000751	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—RRM1—multiple sclerosis	3.94e-05	0.000751	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.94e-05	0.00075	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.94e-05	0.00075	CbGpPWpGaD
Nateglinide—SLC15A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.92e-05	0.000746	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CYP24A1—multiple sclerosis	3.9e-05	0.000743	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CYP27B1—multiple sclerosis	3.9e-05	0.000743	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—SRM—multiple sclerosis	3.88e-05	0.000739	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	3.86e-05	0.000735	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.81e-05	0.000726	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	3.81e-05	0.000725	CbGpPWpGaD
Nateglinide—CYP3A7—Biological oxidations—POMC—multiple sclerosis	3.71e-05	0.000706	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—TGFB1—multiple sclerosis	3.7e-05	0.000705	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—IL1B—multiple sclerosis	3.69e-05	0.000702	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—IL2—multiple sclerosis	3.67e-05	0.000699	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—IL2RA—multiple sclerosis	3.64e-05	0.000693	CbGpPWpGaD
Nateglinide—PTGS1—Biological oxidations—POMC—multiple sclerosis	3.6e-05	0.000685	CbGpPWpGaD
Nateglinide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.59e-05	0.000683	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GPC5—multiple sclerosis	3.57e-05	0.000679	CbGpPWpGaD
Nateglinide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.56e-05	0.000677	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PLEK—multiple sclerosis	3.53e-05	0.000672	CbGpPWpGaD
Nateglinide—ABCC4—Ectoderm Differentiation—MYC—multiple sclerosis	3.52e-05	0.00067	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—TNF—multiple sclerosis	3.46e-05	0.000658	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—VDR—multiple sclerosis	3.41e-05	0.000649	CbGpPWpGaD
Nateglinide—ABCC4—NRF2 pathway—TGFB1—multiple sclerosis	3.35e-05	0.000639	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CYP24A1—multiple sclerosis	3.35e-05	0.000638	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CYP27B1—multiple sclerosis	3.35e-05	0.000638	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	3.31e-05	0.00063	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—PABPC1—multiple sclerosis	3.31e-05	0.00063	CbGpPWpGaD
Nateglinide—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	3.29e-05	0.000626	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	3.28e-05	0.000625	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.28e-05	0.000624	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.23e-05	0.000614	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.23e-05	0.000614	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	3.09e-05	0.000588	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GPC5—multiple sclerosis	3.07e-05	0.000584	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.06e-05	0.000582	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—RPL5—multiple sclerosis	2.98e-05	0.000568	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—RRM1—multiple sclerosis	2.96e-05	0.000563	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	2.93e-05	0.000558	CbGpPWpGaD
Nateglinide—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.91e-05	0.000554	CbGpPWpGaD
Nateglinide—UGT1A9—NRF2 pathway—TGFB1—multiple sclerosis	2.9e-05	0.000552	CbGpPWpGaD
Nateglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.89e-05	0.000551	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—SRM—multiple sclerosis	2.89e-05	0.000551	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	2.82e-05	0.000537	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	2.82e-05	0.000537	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—IL6—multiple sclerosis	2.79e-05	0.000531	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—MAPK1—multiple sclerosis	2.75e-05	0.000524	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP27B1—multiple sclerosis	2.73e-05	0.00052	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP24A1—multiple sclerosis	2.73e-05	0.00052	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—IL2RA—multiple sclerosis	2.71e-05	0.000517	CbGpPWpGaD
Nateglinide—CYP3A5—Biological oxidations—POMC—multiple sclerosis	2.68e-05	0.00051	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—TNF—multiple sclerosis	2.68e-05	0.000509	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.67e-05	0.000509	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	2.67e-05	0.000508	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—MAPK1—multiple sclerosis	2.67e-05	0.000508	CbGpPWpGaD
Nateglinide—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	2.65e-05	0.000505	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—ALB—multiple sclerosis	2.63e-05	0.000501	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GPC5—multiple sclerosis	2.58e-05	0.000491	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—RRM1—multiple sclerosis	2.54e-05	0.000484	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GPC5—multiple sclerosis	2.5e-05	0.000476	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SRM—multiple sclerosis	2.49e-05	0.000474	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—SELE—multiple sclerosis	2.49e-05	0.000473	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—TGFB1—multiple sclerosis	2.46e-05	0.000468	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.42e-05	0.00046	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	2.41e-05	0.000458	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.38e-05	0.000454	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	2.38e-05	0.000454	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—BCHE—multiple sclerosis	2.37e-05	0.000451	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	2.36e-05	0.00045	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—PGR—multiple sclerosis	2.35e-05	0.000447	CbGpPWpGaD
Nateglinide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.35e-05	0.000447	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	2.34e-05	0.000446	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—BCHE—multiple sclerosis	2.3e-05	0.000438	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.29e-05	0.000437	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.28e-05	0.000434	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—BCHE—multiple sclerosis	2.26e-05	0.000431	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—IL6—multiple sclerosis	2.16e-05	0.000411	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.15e-05	0.000409	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—RRM1—multiple sclerosis	2.14e-05	0.000407	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.14e-05	0.000406	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—IL2—multiple sclerosis	2.13e-05	0.000406	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	2.13e-05	0.000405	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—RRM1—multiple sclerosis	2.07e-05	0.000394	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SRM—multiple sclerosis	2.06e-05	0.000392	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SRM—multiple sclerosis	2.04e-05	0.000388	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	2.04e-05	0.000388	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	2.04e-05	0.000388	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.99e-05	0.000379	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.97e-05	0.000375	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.97e-05	0.000375	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—IL6—multiple sclerosis	1.97e-05	0.000375	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—ALB—multiple sclerosis	1.96e-05	0.000374	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TYK2—multiple sclerosis	1.96e-05	0.000373	CbGpPWpGaD
Nateglinide—CYP2D6—Biological oxidations—POMC—multiple sclerosis	1.91e-05	0.000363	CbGpPWpGaD
Nateglinide—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.89e-05	0.00036	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GPC5—multiple sclerosis	1.86e-05	0.000355	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—ITGA4—multiple sclerosis	1.8e-05	0.000342	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.8e-05	0.000342	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—IFNB1—multiple sclerosis	1.78e-05	0.00034	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP24A1—multiple sclerosis	1.76e-05	0.000334	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP27B1—multiple sclerosis	1.76e-05	0.000334	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.72e-05	0.000327	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	1.72e-05	0.000327	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.7e-05	0.000323	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—BCHE—multiple sclerosis	1.7e-05	0.000323	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.69e-05	0.000322	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TGFB1—multiple sclerosis	1.66e-05	0.000317	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—VDR—multiple sclerosis	1.64e-05	0.000313	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—MAPK1—multiple sclerosis	1.63e-05	0.000311	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.61e-05	0.000306	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GPC5—multiple sclerosis	1.61e-05	0.000306	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—IL2—multiple sclerosis	1.59e-05	0.000303	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.54e-05	0.000294	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—MMP9—multiple sclerosis	1.54e-05	0.000294	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.54e-05	0.000294	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.48e-05	0.000282	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—BCHE—multiple sclerosis	1.46e-05	0.000278	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.45e-05	0.000276	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.45e-05	0.000276	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.44e-05	0.000274	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.44e-05	0.000274	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—APOE—multiple sclerosis	1.43e-05	0.000271	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.4e-05	0.000267	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.4e-05	0.000266	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—APOE—multiple sclerosis	1.38e-05	0.000263	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.38e-05	0.000263	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—STAT3—multiple sclerosis	1.37e-05	0.000261	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—APOE—multiple sclerosis	1.36e-05	0.000259	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—MYC—multiple sclerosis	1.36e-05	0.000258	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SRM—multiple sclerosis	1.35e-05	0.000256	CbGpPWpGaD
Nateglinide—ALB—Metabolism—RRM1—multiple sclerosis	1.33e-05	0.000253	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.33e-05	0.000252	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.31e-05	0.00025	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TGFB1—multiple sclerosis	1.27e-05	0.000242	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.26e-05	0.00024	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—MAPK1—multiple sclerosis	1.25e-05	0.000238	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.25e-05	0.000237	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TGFB1—multiple sclerosis	1.24e-05	0.000236	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—IL2RA—multiple sclerosis	1.23e-05	0.000234	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.23e-05	0.000234	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—POMC—multiple sclerosis	1.22e-05	0.000233	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—MAPK1—multiple sclerosis	1.22e-05	0.000232	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—BCHE—multiple sclerosis	1.19e-05	0.000227	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TNF—multiple sclerosis	1.19e-05	0.000226	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—POMC—multiple sclerosis	1.19e-05	0.000226	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—POMC—multiple sclerosis	1.17e-05	0.000223	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—ALB—multiple sclerosis	1.12e-05	0.000213	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.1e-05	0.000209	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.09e-05	0.000207	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.09e-05	0.000207	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—ALB—multiple sclerosis	1.08e-05	0.000206	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.07e-05	0.000203	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—ALB—multiple sclerosis	1.07e-05	0.000203	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.03e-05	0.000197	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—APOE—multiple sclerosis	1.02e-05	0.000195	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—IL6—multiple sclerosis	9.59e-06	0.000183	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	9.48e-06	0.00018	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	9.48e-06	0.00018	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—BCHE—multiple sclerosis	8.87e-06	0.000169	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.87e-06	0.000169	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—APOE—multiple sclerosis	8.78e-06	0.000167	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—POMC—multiple sclerosis	8.78e-06	0.000167	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GPC5—multiple sclerosis	8.67e-06	0.000165	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.45e-06	0.000161	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ALB—multiple sclerosis	8e-06	0.000152	CbGpPWpGaD
Nateglinide—ALB—Metabolism—BCHE—multiple sclerosis	7.64e-06	0.000145	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—POMC—multiple sclerosis	7.54e-06	0.000144	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—APOE—multiple sclerosis	7.38e-06	0.000141	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.26e-06	0.000138	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—IL2—multiple sclerosis	7.2e-06	0.000137	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—RRM1—multiple sclerosis	7.18e-06	0.000137	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—APOE—multiple sclerosis	7.16e-06	0.000136	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ALB—multiple sclerosis	6.88e-06	0.000131	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.62e-06	0.000126	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MYC—multiple sclerosis	6.53e-06	0.000124	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—POMC—multiple sclerosis	6.34e-06	0.000121	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—BCHE—multiple sclerosis	6.31e-06	0.00012	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—BCHE—multiple sclerosis	6.25e-06	0.000119	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—POMC—multiple sclerosis	6.15e-06	0.000117	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ALB—multiple sclerosis	5.78e-06	0.00011	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TGFB1—multiple sclerosis	5.62e-06	0.000107	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ALB—multiple sclerosis	5.61e-06	0.000107	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—MAPK1—multiple sclerosis	5.51e-06	0.000105	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—APOE—multiple sclerosis	5.34e-06	0.000102	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APOE—multiple sclerosis	4.6e-06	8.75e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—POMC—multiple sclerosis	4.59e-06	8.73e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ALB—multiple sclerosis	4.18e-06	7.96e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.12e-06	7.85e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—POMC—multiple sclerosis	3.95e-06	7.52e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOE—multiple sclerosis	3.8e-06	7.23e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOE—multiple sclerosis	3.76e-06	7.16e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—POMC—multiple sclerosis	3.26e-06	6.21e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—POMC—multiple sclerosis	3.23e-06	6.15e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALB—multiple sclerosis	2.97e-06	5.66e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALB—multiple sclerosis	2.95e-06	5.61e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOE—multiple sclerosis	2.48e-06	4.72e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—POMC—multiple sclerosis	2.13e-06	4.06e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALB—multiple sclerosis	1.94e-06	3.7e-05	CbGpPWpGaD
